Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 620

1.

Personalised asthma action plans for adults with asthma.

Gatheral TL, Rushton A, Evans DJ, Mulvaney CA, Halcovitch NR, Whiteley G, Eccles FJ, Spencer S.

Cochrane Database Syst Rev. 2017 Apr 10;4:CD011859. doi: 10.1002/14651858.CD011859.pub2. Review.

PMID:
28394084
2.

Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.

Howcroft M, Walters EH, Wood-Baker R, Walters JA.

Cochrane Database Syst Rev. 2016 Dec 19;12:CD005074. doi: 10.1002/14651858.CD005074.pub4. Review.

PMID:
27990628
3.

Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.

Chauhan BF, Jeyaraman MM, Singh Mann A, Lys J, Abou-Setta AM, Zarychanski R, Ducharme FM.

Cochrane Database Syst Rev. 2017 Mar 16;3:CD010347. doi: 10.1002/14651858.CD010347.pub2. Review.

PMID:
28301050
4.

Self-management for bronchiectasis.

Kelly C, Grundy S, Lynes D, Evans DJ, Gudur S, Milan SJ, Spencer S.

Cochrane Database Syst Rev. 2018 Feb 7;2:CD012528. doi: 10.1002/14651858.CD012528.pub2. Review.

PMID:
29411860
5.

Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.

Kew KM, Dahri K.

Cochrane Database Syst Rev. 2016 Jan 21;(1):CD011721. doi: 10.1002/14651858.CD011721.pub2. Review.

PMID:
26798035
6.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.

Kew KM, Evans DJ, Allison DE, Boyter AC.

Cochrane Database Syst Rev. 2015 Jun 2;(6):CD011438. doi: 10.1002/14651858.CD011438.pub2. Review.

PMID:
26031392
7.

Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.

Lenferink A, Brusse-Keizer M, van der Valk PD, Frith PA, Zwerink M, Monninkhof EM, van der Palen J, Effing TW.

Cochrane Database Syst Rev. 2017 Aug 4;8:CD011682. doi: 10.1002/14651858.CD011682.pub2. Review.

PMID:
28777450
8.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.

Anderson DE, Kew KM, Boyter AC.

Cochrane Database Syst Rev. 2015 Aug 24;(8):CD011397. doi: 10.1002/14651858.CD011397.pub2. Review.

PMID:
26301488
9.

Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.

Kew KM, Quinn M, Quon BS, Ducharme FM.

Cochrane Database Syst Rev. 2016 Jun 7;(6):CD007524. doi: 10.1002/14651858.CD007524.pub4. Review.

PMID:
27272563
10.

Antibiotics for exacerbations of asthma.

Normansell R, Sayer B, Waterson S, Dennett EJ, Del Forno M, Dunleavy A.

Cochrane Database Syst Rev. 2018 Jun 25;6:CD002741. doi: 10.1002/14651858.CD002741.pub2. Review.

PMID:
29938789
11.

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.

Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD007949. doi: 10.1002/14651858.CD007949.pub2. Review.

PMID:
26594816
12.

Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.

Ahmad S, Kew KM, Normansell R.

Cochrane Database Syst Rev. 2015 Jun 19;(6):CD011306. doi: 10.1002/14651858.CD011306.pub2. Review.

PMID:
26089258
13.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma.

Evans DJ, Kew KM, Anderson DE, Boyter AC.

Cochrane Database Syst Rev. 2015 Jul 21;(7):CD011437. doi: 10.1002/14651858.CD011437.pub2. Review.

PMID:
26196545
14.

Interventions to improve adherence to inhaled steroids for asthma.

Normansell R, Kew KM, Stovold E.

Cochrane Database Syst Rev. 2017 Apr 18;4:CD012226. doi: 10.1002/14651858.CD012226.pub2. Review.

PMID:
28417456
15.

Inhaled magnesium sulfate in the treatment of acute asthma.

Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, Powell C.

Cochrane Database Syst Rev. 2017 Nov 28;11:CD003898. doi: 10.1002/14651858.CD003898.pub6. Review.

PMID:
29182799
16.

Sublingual immunotherapy for asthma.

Normansell R, Kew KM, Bridgman AL.

Cochrane Database Syst Rev. 2015 Aug 28;(8):CD011293. doi: 10.1002/14651858.CD011293.pub2. Review.

PMID:
26315994
17.

Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department.

Kew KM, Kirtchuk L, Michell CI.

Cochrane Database Syst Rev. 2014 May 28;(5):CD010909. doi: 10.1002/14651858.CD010909.pub2. Review.

PMID:
24865567
18.

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.

Kew KM, Karner C, Mindus SM, Ferrara G.

Cochrane Database Syst Rev. 2013 Dec 16;(12):CD009019. doi: 10.1002/14651858.CD009019.pub2. Review.

PMID:
24343671
19.

Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults.

Chong J, Haran C, Chauhan BF, Asher I.

Cochrane Database Syst Rev. 2015 Jul 22;(7):CD011032. doi: 10.1002/14651858.CD011032.pub2. Review.

PMID:
26197430
20.

Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.

Kirkland SW, Cross E, Campbell S, Villa-Roel C, Rowe BH.

Cochrane Database Syst Rev. 2018 Jun 2;6:CD012629. doi: 10.1002/14651858.CD012629.pub2. Review.

PMID:
29859017

Supplemental Content

Support Center